Advocates urge Cepheid to take immediate action necessary to bring about affordable, equitable, and expanded access to GeneXpert TB testing.

The World Health Organization releases an advocacy and communications package to support awareness building and drive action across all levels, in the lead up to and on World TB Day.

The Stop TB Partnership releases the toolkit for the World TB Day campaign Yes! We Can End TB.

Treatment Action Group launches the 2022 Tuberculosis Treatment Pipeline Report.

Yes! We Can End TB.
The theme brings attention to TB and that it is in our collective power to end TB by 2030 and therefore reach the Sustainable Development Goals.

The Council will facilitate the licensing and use of effective novel TB vaccines catalysing high-level alignment between funders, global agencies, governments and end users in identifying and overcoming barriers to TB vaccine development.

A few recent Campaign updates from Treatment Action Group and allies.
Contact david.branigan@treatmentactiongroup.org for more information on how to be part of the 1/4/6x24 Campaign.

Advocates urge Johnson & Johnson to correct its course and stop blocking entry of generic versions of bedaquiline into the global market and into countries.

Médecins Sans Frontières urges the Indian Patent Office to reject the secondary patent application filed by Johnson & Johnson to prevent the company from extending its monopoly on bedaquiline beyond the primary patent’s expiry in July 2023.

The World Health Organization releases updated guidelines and a supporting operational handbook on the treatment of drug-resistant TB featuring major improvements in treatment options for people with multidrug-resistant or rifampicin-resistant TB.